-
Special Interest Groups
- Biosimilars
- Clinical Outcome Assessment
- Digital Health
- Health Preference Research
- Medical Devices and Diagnostics
-
Medication Adherence and Persistence
-
Nutrition Economics
- Oncology
- Open Source Models
- Patient-Centered
- Precision Medicine and Advanced Therapies
- Rare Disease
- Real-World Evidence (RWE)
- Statistical Methods in HEOR
-
Task Forces
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) II
- Joint HTAi - ISPOR Deliberative Processes for HTA
- Machine Learning Methods in HEOR
-
Measurement Comparability Between Modes of Administration of PROMs
- Performance Outcome (PerfO) Assessments
- Quantitative Benefit-Risk Assessment
- Systematic Reviews with Cost and Cost-Effectiveness Outcomes
- Using Patient Preferences to Inform Decision Making
- Joint ISPE-ISPOR Special Task Force
- Councils & Roundtables
- Global Groups
- Students
-
New Professionals
-
Professional Development Resources
- What is the Impact of GDPR on the HEOR Community
- Good Practices for HTA - What is out there and how do I use it
- ISPOR & AACP Joint Webinar – “Tips for Securing a Post-Doctoral Fellowship”
- You Are Creative: Research is the First Step
- AMCP eDossier System @ FormularyDecisions.com Demo and Practical Application
- Good Practices for a Successful Job Search
- Leveraging The Power Of LinkedIn
- Internships & Fellowships: Career Opportunities for the Future
- My Career Path
- Career Advice Across the Globe
- "My ISPOR Story" - Zeba Khan
- "My ISPOR Story" - Lou Garrison
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 1
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 2
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 3
-
Professional Development Resources
Mission
To curate an ongoing dialog regarding issues around creating, disseminating, sharing, evaluating, and updating open source cost-effectiveness and comparative effectiveness models.
Goal
- Define the issues surrounding open source models
- Improve model transparency, updating, idea exchange, currency, and policy development
- Provide a centralized platform to facilitate discussion and dissemination of information on the topic of open source models
Background
The world is moving towards more openness, sharing, and collaboration. There has been a marked growth in open science; however, there is currently no efficient process for creating, sharing, evaluating, and updating health economic models. This situation can result in the expensive re-creation of existing models or the inappropriate use of outdated models. Moreover, models are often not updated at all. To address these issues, certain institutions have begun to promote and encourage access to open source models and some journals make models available to reviewers upon their request. However, it is unclear how these various groups will encourage widespread model openness and transparency in a repository or otherwise, given intellectual property (IP) rights, costs to initiate and sustain, and legal, information technology, and other issues surrounding such an endeavor. This Special Interest Group has therefore been founded to address these and other challenges and aspects related to the concept of open source models.
Leadership
Renée Arnold, PharmD, RPh
Christopher Sampson, MSc, BA
Working Groups
Member Engagement
- Talitha Feenstra, PhD, Associate Professor, Groningen University/RIVM, Groningen, Netherlands
- Lei Si, Senior Research Fellow, The George Institute for Global Health, Sydney, Australia
- Will Herring, PhD, Senior Director, Health Economics, RTI Health Solutions, North Carolina, USA
- Nancy Risebrough, Senior Principal, Global Health Economist, ICON Global HTA, Toronto, Canada